biOasis Technologies Ord Shs BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

GREY:BIOAF - Post by User

biOasis Technologies Ord Shs > Where are the links?

<< Previous

Bullboard Posts

Next >>

Comment by InitiumMMXXIIIon Jan 03, 2025 11:23pm

37 Views

Post# 36387146

RE:RE:RE:RE:RE:RE:RE:RE:Where are the links?

G'nite, zwerp. Don't let Bioasis and this forum trouble your slumber.

When you come back, it will all still be waiting for you.

Maybe we could discuss the Chiesi question.

Bring those xB3 links with you. You shouldn't let that "failed" thing hang out there too long. We can see how much it bothers you.

Yawn...

jd

<< Previous

Bullboard Posts

Next >>

Cannabix advances marijuana breathalyzer tech